Caleb Howard, PA
Medical · Claremont, NHNPI 1962061663
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.7%), consulting fees and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by LEO Pharma Inc. at 34.0% of the total. Reporting peaked in 2024 at $916 and has fallen 63.4% since, to $335 in 2025.
Across 62 payments — averaging $36.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$777
- Johnson & Johnson$656
- AbbVie$194
- Regeneron Healthcare Solutions, Inc.$108
- Sanofi-aventis U.S. LLC$100
- Sun Pharmaceutical Industries Inc.$90
- plus $360 from 7 others
What the payments were for
- Consulting fees$71831%
- Food & beverage$1,29657%
- Education$27212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 4 | $777 |
| Johnson & Johnson(2 entities) | 25 | $656 |
| AbbVie | 9 | $194 |
| Regeneron Healthcare Solutions, Inc. | 3 | $108 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Sun Pharmaceutical Industries Inc. | 1 | $90 |
| Galderma Laboratories, L.p. | 5 | $88 |
| E.r. Squibb & Sons, L.L.C. | 5 | $79 |
| Organon | 1 | $56 |
| Novartis | 3 | $53 |
| Sanofi | 3 | $52 |
| Strata Skin Sciences, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
How this compares
$2,285 in reported general payments places this provider in the 85th percentile of 124 medical providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 27 | $99,140 |
| Humira PenAdalimumab | 11 | $74,854 |
| Dupixent SyringeDupilumab | 20 | $74,651 |
| Metronidazole | 70 | $3,328 |
| Clobetasol Propionate | 91 | $2,990 |
| Triamcinolone Acetonide | 163 | $2,282 |
| Clindamycin Phosphate | 46 | $1,599 |
| Ketoconazole | 83 | $1,519 |
| Halobetasol Propionate | 22 | $1,296 |
| Doxycycline Hyclate | 50 | $1,096 |
| Econazole Nitrate | 22 | $864 |
| Fluorouracil | 11 | $779 |
| Alclometasone Dipropionate | 20 | $730 |
| Minoxidil | 29 | $630 |
| Mometasone Furoate | 21 | $324 |
Paid to pharmacies, not to this prescriber.
Other medical in Claremont
- Ashwin KumarClaremont$956
- Kira SchachingerClaremont$420
- Holly PelletierManchester$124K
- Kathrine CecilNashua$9K
- Alyssa DunnDerry$8K
- Kelly HochstetlerDover$8K
- Stacy FilionConcord$5K
- Jacqueline FournierConcord$5K
- Andrea BourkeLondonderry$5K
- Heather BigosDover$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.